Skip to main content
. Author manuscript; available in PMC: 2016 May 15.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jun 24;0:57–62. doi: 10.1016/j.jchromb.2015.06.017

Fig. 3.

Fig. 3

Representative concentration-time curves of miltefosine plasma concentrations (solid line) and intracellular miltefosine concentrations (dashed line) for six cutaneous leishmaniasis patients. The vertical grey dashed line indicates the end of treatment.